Americord Registry Partners with Ovuline's Pregnancy App

NEW YORK, May 26, 2015 /PRNewswire/ -- Americord Registry announced today that it has partnered with Ovuline's pregnancy app, Ovia, to provide expecting parents with the information they need on cord blood, cord tissue, and placenta tissue banking.

Logo - http://photos.prnewswire.com/prnh/20150526/218338LOGO

"We're thrilled to work alongside Ovuline," said Americord CEO Martin Smithmyer. "They share our firm belief in starting a conversation with expecting parents and giving them important, engaging, and personalized information to guide them through their pregnancy."

Ovia's Pregnancy App features unique feedback to each user based on her engagement and daily reporting. The result is a highly personalized app experience that provides expecting parents with answers to their individual pregnancy needs.

"Americord and Ovia are ideal partners," Smithmyer said. "Cord blood banking is a big decision and Americord believes in educating parents on their options throughout their pregnancy so that they can make the right choice for their family. Ovia helps to bring the most crucial information to expecting mothers and fathers when they need it."

Americord is committed to furthering stem cell banking technologies and educating parents on the future possibilities for stem cell treatments and therapies. As the only cord blood bank to offer Cord Blood 2.0, Americord allows parents to collect up to twice as many stem cells as the industry standard. The number of stem cells collected is crucial because traditional cord blood banking often collects only enough stem cells to treat a child under 65 pounds. With more stem cells, it becomes possible to treat an adolescent and even an adult.

"We are very proud to partner with Americord, a true pioneer that, like Ovuline, values the health of mothers and their babies as a top priority," said Paris Wallace, co-founder and CEO of Ovuline. "Our mobile apps empower women to make informed choices based on their personalized experiences and by working with Americord, we're able to educate our users on the importance of cord blood banking."

About Americord Registry

Americord Registry is a leader in the advancement of umbilical cord blood, cord tissue and placenta tissue banking. Americord collects, processes, and stores newborn stem cells from umbilical cord blood for future medical or therapeutic use, including the treatment of more than 80 blood diseases such as sickle cell anemia and leukemia. Founded in 2008, Americord is registered with the FDA and operates in all 50 states. The company's laboratory is CLIA Certified, accredited by the AABB and complies with all federal and state guidelines and applicable licenses. Americord is headquartered in New York, NY. You may visit Americord Registry's website at www.americordblood.com for more information.

About Ovuline

Ovuline uses big data and mobile apps to help women conceive faster and have healthier pregnancies. Ovuline's mobile apps Ovia Fertility and Ovia Pregnancy are the leading women's health apps in the Apple App Store and Google Play, having helped over 2 million women track their cycles and start healthy families. Developed by Harvard scientists and the nation's leading fertility and pregnancy experts, Ovia uses data science and expert analysis to give women personalized feedback on their unique cycles and pregnancies.

PRESS CONTACT:
Raechel Sherwood
[email protected]
866-503-6005 ext. 944

SOURCE Americord Registry

Related Links

http://www.americordblood.com

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED